What was filed
Vimta Labs' board met on July 20, 2026, and approved the company's unaudited financial results for the first quarter of FY27, the three months ended June 30, 2026. The audit committee reviewed and recommended the results, and the statutory auditors, Gattamaneni & Co., issued a limited-review report with an unmodified conclusion.
The company operates in a single reportable segment — Contract Research and Testing Services — and reported no subsidiaries, associates or joint ventures for the quarter or the comparable periods.
The quarter in context
Revenue from operations and net profit both grew against the same quarter a year earlier, while remaining close to the immediately preceding March 2026 quarter, per the filing. Depreciation and amortisation rose year-on-year, and the quarter carried no exceptional items — unlike the full year to March 2026, which absorbed a one-off gratuity past-service cost tied to the new labour codes.
The filing also notes that the nomination and remuneration committee granted stock options to eligible employees at the same July 20, 2026 meeting, under the company's 2021 ESOP plan.
The FSSAI lab arrangement
The results continue to reflect Vimta's public-private-partnership agreement signed with the Food Safety and Standards Authority of India (FSSAI) in June 2021 to set up, operate and transfer a National Food Testing Laboratory at JNPT, Mumbai. The company accounts for this as a service concessionaire arrangement, splitting revenue and costs between lab-setup services and operation-and-maintenance services. The lab-setup portion contributed a small figure to the quarter's revenue, as detailed in the filing's notes.